Dr. Roz McCarthy
Founder & CEOMinorities for Medical MarijuanaRoz is the Founder/CEO of Minorities for Medical Marijuana (M4MM) the largest community based national nonprofit organization serving communities of color as it relates to the cannabis and hemp industry. She also is the Founder/CEO of Black Buddha Cannabis. Black Buddha Cannabis (BBC) is a social impact driven brand focused on creating best in class lifestyle and wellness products in partnership with cannabis operators legalized states. Roz has been recognized as one of the top 100 most influential figures in the cannabis industry, and her organization has been honored as the Organization of the Year. With eight years of dedicated advocacy, Roz’s contributions have been featured or mentioned in more than 50 media publications and outlets. Prior to her entry into the Cannabis industry Roz spent 30+ years in the health care industry working as a branding and business development executive for powerhouse Fortune 500 companies like Bristol Myers & Squibb, VITAS Corporation, Maxim Healthcare and Phoenix House.
Social Equity in Cannabis: Lessons Learned and the Path to Reform
Social equity was meant to be the cannabis industry's correction to decades of harm. Years in, the results are uneven. Some cannabis equity programs
Social equity was meant to be the cannabis industry's correction to decades of harm. Years in, the results are uneven. Some cannabis equity programs have opened real doors, while others have stalled under licensing backlogs, capital gaps, and rules
Social equity was meant to be the cannabis industry's correction to decades of harm. Years in, the results are uneven. Some cannabis equity programs have opened real doors, while others have stalled under licensing backlogs, capital gaps, and rules that look good on paper but rarely survive in the market. This session takes an honest look at what's working, what isn't, and where the next round of reform must go.
This discussion moves past goo
Social equity was meant to be the cannabis industry's correction to decades of harm. Years in, the results are uneven. Some cannabis equity programs have opened real doors, while others have stalled under licensing backlogs, capital gaps, and rules that look good on paper but rarely survive in the market. This session takes an honest look at what's working, what isn't, and where the next round of reform must go.
This discussion moves past good intentions to evaluate outcomes with clear eyes. We'll examine the structural and legislative levers that can turn equity promises into lasting ownership, participation, and wealth.
